Covid-19 Pharma Insights
Moderna v Pfizer-BioNTech: Lessons to be learnt from post-pandemic disputes
Dr. Nicholas Jones, partner and patent attorney at Withers & Rogers, discusses what the pharma industry can learn from its experiences of working collaboratively during the COVID-19 pandemic by establishing best practice and minimising risks. Read more
13 Sep 2022
Using genomic sequencing to predict COVID’s next move
Brittany Niccum, Beckman Coulter Life Sciences, shares how genomic sequencing and laboratory automation can monitor new variants of COVID and potentially nip them in the bud, before they transform into future pandemics. Read more
17 Aug 2022
Wastewater is anything but a waste: It could even prevent the next pandemic
Ari Goldfarb, CEO, Kando, discusses how innovative technologies and artificial intelligence tools are advancing wastewater analysis and could potentially mitigate the effects, or even prevent, future pandemics. Read more
26 Jul 2022
Opinion: Pandemic preparedness
Martin Stocks, CEO of Iceni Glycoscience, discusses how preparedness for the pandemic relies on leveraging the technologies and insights of innovative startups. Read more
25 May 2022
The MedTalk Podcast - How iiCON is driving innovation in the UK and beyond
We speak to professor Janet Hemingway, the founding director of the Infection Innovation Consortium (iiCON) to find out all about the work the organisation has done throughout the Covid-19 pandemic. Read more
1 Feb 2022
The future of Covid-19 vaccinations
Ivor Campbell managing director of Snedden Campbell discusses the future of Covid-19 vaccination and why testing is crucial amidst falling antibody levels. Read more
30 Nov 2021
PrecisionLife and Metrodora Institute Partner
PrecisionLife and Metrodora Institute are co-investing in a first-of-its-kind partnership to jumpstart the diagnosis and treatment options for a range of complex, chronic diseases including Long COVID, ME/CFS, ALS, Sjögren's syndrome, and many more. Read more
26 Feb 2024
Osivax Announce First-in-Human Phase 1 Vaccination Trial
Osivax have announced that the first participant has been vaccinated in its new Phase 1 trial (NCT06128382) evaluating OVX033, a broad-spectrum sarbecovirus vaccine candidate. Read more
15 Feb 2024
Virios Therapeutics to Develop Long Covid Therapy
Virios Therapeutics, Inc have announced plans for advancing IMC-2 (combination of valacyclovir and celecoxib) as a treatment for the fatigue, orthostatic intolerance and other symptoms associated with long covid. Read more
24 Jan 2024
What’s trending in point-of-care diagnostics?
Commercial director, Rory O’Keeffe, Europlaz, examines the latest innovations that the team believes will be transformative to future clinical pathways. Read more
17 Jul 2024
The Practical Impact of Generative AI in Life Science Manufacturing
Life sciences manufacturers continuously strive for accelerated launch, increased capacity for in-demand medicine, enhanced security of supply and improved sustainability. Read more
16 Jul 2024
A Short Guide to Stability Studies
Paul Barr, Principal Scientist at Broughton, outlines the key factors when it comes to stability testing for drug delivery devices. Read more
28 Jun 2024
How Ready Are You? Annex 1 and the Impact of Primary Packaging
Niamh Bissett, Director, Operations, PMO, West Pharmaceutical Services discusses Annex 1 and the Impact of Primary Packaging in our latest EPM Online insight. Read more
18 Jun 2024
Q&A: Purolite's Felix Solamo
We caught up with Purolite's Felix Solamo to look back on Bio International 2024. Read more
18 Jun 2024
Patent Lifecycle Management is Key for Cell and Gene Therapy Innovators
Justin Wilson, partner and pharmaceuticals & gene therapy sector specialist at European intellectual property law firm Withers & Rogers explores how patent lifecycle management is key for cell and gene therapy innovators. Read more
17 Jun 2024